Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Backers
2
RA Capital Management, Lightstone Ventures
Momentum
0/100
no fresh signals
Registers and programsofficial lists and records that name the company
Legal entity Introduction Alchemab Therapeutics Ltd its site
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Protai leverages proteomics and AI to accelerate drug discovery, enabling faster identification of novel therapeutic targets and biomarkers.
About Us Senior Management Team Board of Directors Clinical Advisory Board Technology Pipeline Overview Migaldendranib (MGB) News Resources…
Company Management Team Board of Directors Scientific Advisory Board Clinical Advisory Board Company History Investors Science Biology…
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need…
Boundless BioSeries C $100M · 3 yr ago • Founded 2018
We at Boundless Bio are pioneers in understanding and treating the most intractable cancers. We have charted a new spatial map of the…
Forward, by Design.. Novel chemistry. Proven pathways. Designed for patient impact.

Overview

Scroll To: About Executive Leadership Senior Leadership Board of Directors Scientific Founders Investors ABOUT Alchemab has developed a highly differentiated platform which enables the identification of novel drug targets and therapeutics by analysis of patient antibody repertoires.